pindolol has been researched along with salmeterol xinafoate in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Douglas, JS; Grandordy, B; Roux, FJ | 1 |
Bertin, B; Jockers, R; Marullo, S; Strosberg, AD | 1 |
Lemoine, H; Teschemacher, A | 1 |
Green, SA; Liggett, SB; Rathz, DA; Schuster, AJ | 1 |
7 other study(ies) available for pindolol and salmeterol xinafoate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
Topics: Adrenergic beta-Agonists; Albuterol; Aminophylline; Animals; Binding, Competitive; Bronchoconstriction; Bronchodilator Agents; Ethanolamines; Female; Fenoterol; Formoterol Fumarate; Guanine Nucleotides; Guinea Pigs; Heart; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lung; Pindolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Trachea | 1996 |
Activation of a beta 2-adrenergic receptor/Gs alpha fusion protein elicits a desensitization-resistant cAMP signal capable of inhibiting proliferation of two cancer cell lines.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Albuterol; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Colforsin; Cyclic AMP; Down-Regulation; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunits, Gs; Iodocyanopindolol; Isoproterenol; Mice; Pindolol; ras Proteins; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Salmeterol Xinafoate; Signal Transduction; Transfection; Tumor Cells, Cultured | 1997 |
Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Binding, Competitive; Bronchodilator Agents; Cattle; Cell Membrane; Ethanolamines; Formoterol Fumarate; In Vitro Techniques; Isoproterenol; Lung; Membranes; Muscle, Smooth; Pindolol; Radioligand Assay; Rats; Receptors, Drug; Salmeterol Xinafoate; Sympathomimetics; Trachea | 1999 |
The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
Topics: Adrenergic beta-Agonists; Albuterol; Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Genotype; Humans; Iodine Radioisotopes; Isoproterenol; Metaproterenol; Pindolol; Polymorphism, Genetic; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline | 2001 |